Field Safety Notices about ADVIA® CC 1200/1800

According to Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), this field safety notices involved a device in Slovenia that was produced by Siemens d.o.o..

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
  • Event Country
  • Event Source
  • Notes / Alerts
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Extra notes in the data
  • Reason
    Siemens diagnostics have identified the possibility of false elevations in advia® chemistry lipase assay analyzers, because of the possibility of transferring reagents and carryover from one or which of the following tests: triglycerides, triglycerides_2, concentrated triglyceride reagent, concentrated cholesterol reagent and direct ldl. .


  • Model / Serial
    REF: 01984894 10311896 All lots
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Source